Abstract: Provided is a liquid pharmaceutical composition having increased stability, and more particularly, a stable liquid pharmaceutical composition including a protein.

Abstract: Provided is a display device including a display panel including light emitting regions and a non-light emitting region adjacent to the light emitting regions, a first insulation layer disposed on the display panel, the first insulation layer having a first refractive index, and having first openings defined in a region overlapping the light emitting regions, a second insulation layer covering the display panel and the first insulation layer and having a second refractive index greater than the first refractive index of the fist insulation layer, a third insulation layer disposed on the second insulation layer, the third insulation layer having the first refractive index, and having second openings defined in a region overlapping the light emitting regions, and a fourth insulation layer covering the second insulation layer and the third insulation layer and the fourth insulation layer having the second refractive index.

Abstract: An electronic device configured to communicate with a host includes: a detecting logic configured to receive an initial command signal and a first completion signal according to the initial command signal after a connection of the host to the electronic device is established, and transmit a detection signal based on a signal transmission policy of the host that has been detected based on the initial command signal and the first completion signal; and a transmitting logic configured to transmit a second completion signal to the host based on the detection signal, wherein the signal transmission policy is different depending on whether the first completion signal is received in response to the second completion signal.

Abstract: The display device includes a display panel, a printed circuit board on which a timing controller is mounted, and a connection film on which a data driver is mounted. Pixels and a gate driving circuit are disposed in a display area of the display panel. The connection film includes output lines connecting the data driver and the display panel, and first connection lines connecting the printed circuit board and the display panel. The first connection lines overlap the first area on which the data driver is mounted and are disposed between the output lines.

Abstract: An electronic device is provided. The electronic device includes a housing, a touchscreen display exposed through a first portion of the housing, a microphone disposed at a second portion of the housing, a speaker disposed at a third portion of the housing, a memory disposed inside the housing, a processor disposed inside the housing, and electrically connected to the display, the microphone, the speaker, and the memory. The memory is configured to store a plurality of application programs, each of which includes a graphic user interface (GUI).

Abstract: The present invention relates to a hydrogel formulation for delivering probiotics including a hydrogel, probiotics and zwitterionic buffer as an active ingredient, a composition for delivering probiotics comprising the same and a method of preparing the same, which adjust and maintain the internal pH of the hydrogel even in the gastric juice environment, thereby increasing the survival rate of the probiotics in the gastric juice and improving the delivery rate to the large intestine, by further adding zwitterionic buffer capable of maintaining pH to the hydrogel encapsulated with probiotics.

Abstract: A pharmaceutical composition for treating Gram negative bacteria-associated infections includes an antibacterial protein that includes at least one selected from the group consisting of a protein having the amino acid sequence as set forth in SEQ ID NO: 1, a protein having the amino acid sequence as set forth in SEQ ID NO: 2, a protein having the amino acid sequence as set forth in SEQ ID NO: 3, a protein having the amino acid sequence as set forth in SEQ ID NO: 4, a protein having the amino acid sequence as set forth in SEQ ID NO: 5, a protein having the amino acid sequence as set forth in SEQ ID NO: 6, a protein having the amino acid sequence as set forth in SEQ ID NO: 7, and a protein having the amino acid sequence as set forth in SEQ ID NO: 8. A method of preparing the antibacterial protein is also disclosed.

Abstract: A secure processor and a semiconductor system including the same is provided. Provided is a system on chip comprising a secure processor, wherein the secure processor includes: a random access memory (RAM) including a RAM cache area storing a page and a timestamp table storing a timestamp, an encryption/decryption engine configured to encrypt the page by using the timestamp, and a direct memory access (DMA) module configured to transmit the encrypted page to a swap area of a first memory disposed outside the system on chip, wherein the first memory includes a tag table area storing a tag generated by the encryption/decryption engine encrypting the page and a timestamp backup area backing up the timestamp, and the swap area, the tag table area, and the time stamp backup area are backed up in a second memory disposed outside the system on chip.

Abstract: Provided is a display device including a display panel including light emitting regions and a non-light emitting region adjacent to the light emitting regions, a first insulation layer disposed on the display panel, the first insulation layer having a first refractive index, and having first openings defined in a region overlapping the light emitting regions, a second insulation layer covering the display panel and the first insulation layer and having a second refractive index greater than the first refractive index of the first insulation layer, a third insulation layer disposed on the second insulation layer, the third insulation layer having the first refractive index, and having second openings defined in a region overlapping the light emitting regions, and a fourth insulation layer covering the second insulation layer and the third insulation layer and the fourth insulation layer having the second refractive index.

Abstract: A polyester resin that exhibits heat resistance and transparency by including at least dispiro[5.1.5.1]tetradecane-7,14-diol as a diol component, and a preparation method of this polyester resin are disclosed. The polyester resin is obtained by copolymerization of two or more glycols in addition to dispiro[5.1.5.1]tetradecane-7,14-diol and dicarboxylic acid component, which may include terephthalic acid. The diol component may include 1,4-cyclohexanedimethanol in a range from 30 to 50 mol % based on 100 mol % of the dicarboxylic acid and dispiro[5.1.5.1]tetradecane-7,14-diol in a range from 5 to 60 mol % based on 100 mol % of the dicarboxylic acid moiety and ethylene glycol.

Abstract: Disclosed are an artificial esophageal structure having a multi-layer structure using three-dimensional bio-printing, and a manufacturing device and manufacturing method therefor. The artificial esophageal structure having a multi-layer structure according to one embodiment of the present invention comprises: a first layer in the shape of a hollow column and having a circular cross section; a second layer which is disposed inside the first layer and which is a column structure that simulates the mucosal layer of the esophagus; and an interlayer support part which is disposed between the first layer and the second layer and which maintains a gap between the layers, wherein the first layer and second layer each comprise: a plurality of column parts disposed at predetermined intervals; and a plurality of strands formed between the plurality of column parts by a dragging technique, and may have a porous structure due to pores between the plurality of strands.

Abstract: A trans-splicing ribozyme capable of splicing a rhodopsin transcript at a target splicing site and containing a sequence that is capable of complementarily binding to a target binding site of the rhodopsin transcript is disclosed. The trans-splicing ribozyme may further containing a desired rhodopsin transcript at 3?-end. The trans-splicing ribozyme may further contains an antisense sequence that is complementary to a region downstream the target binding site of the rhodopsin transcript. A nucleotide molecule encoding the trans-splicing ribozyme is also disclosed. Delivery systems to delivery the nucleotide molecule and/or the trans-splicing ribozyme to target tissue or cells as well as uses of the trans-splicing ribozyme, the nucleotide molecule, delivery systems, or pharmaceutical compositions containing any of them are also disclosed.

Abstract: Provided is a carboxylic acid-modified nitrile-based copolymer latex, and more particularly, provided are a carboxylic acid-modified nitrile-based copolymer latex which includes a carboxylic acid-modified nitrile-based copolymer including a monomer-derived repeating unit; and a repeating unit derived from a monomer represented by Chemical Formula 1 below, the monomer-derived repeating unit including a conjugated diene-based monomer-derived repeating unit, an ethylenically unsaturated nitrile-based monomer-derived repeating unit, and an ethylenically unsaturated acid monomer-derived repeating unit (see description of the present invention), a method for preparing a carboxylic acid-modified nitrile-based copolymer latex, a latex composition for dip-forming including the copolymer latex, and an article formed by the composition.

Abstract: Disclosed is a method of preparing a carboxylic acid modified-nitrile based copolymer latex including: initiating emulsion polymerization of a monomer mixture including a conjugated diene-based monomer, ethylenic unsaturated nitrile-based monomer, ethylenic unsaturated acid monomer, and water-soluble monomer in the presence of water and 0.01 to 0.1 parts by weight of a lipid-soluble initiator based on 100 parts by weight of total of monomer mixture, and at a weight ratio (M/W) of the monomer mixture to water of 1.1 to 1.4 (S10); adding water when the polymerization conversion rate is 30 to 40% at a weight ratio (M/W) of 0.8 to 1.0 (S20); and adding water when the polymerization conversion rate is 60 to 70% at a weight ratio (M/W) of 0.6 to 0.7 (S30), when the polymerization conversion rate is between ?10% and <60%, 0.1 to 2.0 parts by weight of sodium naphthalene sulfonate formaldehyde condensate based on 100 parts by weight of the total monomer mixture is introduced.

Abstract: A pharmaceutical composition for treating Gram negative bacteria-associated infections includes an antibacterial protein that includes at least one selected from the group of a protein having the amino acid sequence as set forth in SEQ ID NO: 1, a protein having the amino acid sequence as set forth in SEQ ID NO: 2, a protein having the amino acid sequence as set forth in SEQ ID NO: 3, a protein having the amino acid sequence as set forth in SEQ ID NO: 4, a protein having the amino acid sequence as set forth in SEQ ID NO: 5, a protein having the amino acid sequence as set forth in SEQ ID NO: 6, a protein having the amino acid sequence as set forth in SEQ ID NO: 7, and a protein having the amino acid sequence as set forth in SEQ ID NO: 8. A method of preparing the antibacterial protein is also disclosed.

Abstract: A battery cell of a venting structure using taping is disclosed. The battery cell includes a battery case including a first case and a second case, at least one of the first and second cases being provided with a receiving part for receiving the electrode assembly, thermally bonded edges for sealing the receiving part being provided outside the receiving part, a positive electrode lead and a negative electrode lead protruding outward from the battery case, and an electrode assembly received in the battery case, the electrode assembly having electrode tabs protruding from one end thereof, the electrode tabs being coupled to the positive electrode lead and the negative electrode lead, wherein seal reinforcement tapes are attached to some of the thermally bonded edges so as to surround outer ends of the some thermally bonded edges.

Abstract: A pharmaceutical composition for treating Gram negative bacteria-associated infections includes an antibacterial protein that includes at least one selected from the group of a protein having the amino acid sequence as set forth in SEQ ID NO: 1, a protein having the amino acid sequence as set forth in SEQ ID NO: 2, a protein having the amino acid sequence as set forth in SEQ ID NO: 3, a protein having the amino acid sequence as set forth in SEQ ID NO: 4, a protein having the amino acid sequence as set forth in SEQ ID NO: 5, a protein having the amino acid sequence as set forth in SEQ ID NO: 6, a protein having the amino acid sequence as set forth in SEQ ID NO: 7, and a protein having the amino acid sequence as set forth in SEQ ID NO: 8. A method of preparing the antibacterial protein is also disclosed.

Abstract: A display device includes an oscillator which generates a reference clock signal having a frequency corresponding to frequency information provided from an external device, a register which stores a signal parameter for the reference clock signal, and the signal parameter indicates the number of pulses of the reference clock signal included in one horizontal time, a data driver which applies data signals to data lines connected to pixels based on the one horizontal time, and a controller which changes the signal parameter based on a change in the frequency of the reference clock signal in a way such that the one horizontal time is maintained substantially constant.